These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4185247)

  • 1. C3 leukotactic factors produced by a tissue protease.
    Hill JH; Ward PA
    J Exp Med; 1969 Sep; 130(3):505-18. PubMed ID: 4185247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase.
    Ward PA; Becker EL
    J Exp Med; 1968 Apr; 127(4):693-709. PubMed ID: 5642465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats.
    Hill JH; Ward PA
    J Exp Med; 1971 Apr; 133(4):885-900. PubMed ID: 4993831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the C5 peptides chemotactic for leukocytes and tumor cells.
    Romualdez AG; Ward PA; Torikata T
    J Immunol; 1976 Nov; 117(5 Pt.2):1762-6. PubMed ID: 62790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural features and biologic properties of fragments obtained by limited proteolysis of C3.
    Conroy MC; Ozols J; Lepow IH
    J Immunol; 1976 Jun; 116(6):1682-7. PubMed ID: 774990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of the inhibition of chemotaxis by phosphonate esters.
    Ward PA; Becker EL
    J Exp Med; 1967 Jun; 125(6):1001-20. PubMed ID: 4164884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotoxis of mononuclear cells.
    Ward PA
    J Exp Med; 1968 Nov; 128(5):1201-21. PubMed ID: 5682943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of the chemotactic behavior of the complement-derived factors, C3a, C5a, and C567, and a bacterial chemotactic factor to their ability to activate the proesterase 1 of rabbit polymorphonuclear leukocytes.
    Becker EL
    J Exp Med; 1972 Feb; 135(2):376-87. PubMed ID: 4551218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.
    Orr FW; Varani J; Kreutzer DL; Senior RM; Ward PA
    Am J Pathol; 1979 Jan; 94(1):75-83. PubMed ID: 569981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils.
    Ward PA; Hill JH
    J Immunol; 1970 Mar; 104(3):535-43. PubMed ID: 4985169
    [No Abstract]   [Full Text] [Related]  

  • 12. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
    Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
    Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
    Desai U; Dickey B; Varani J; Kreutzer DL
    J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement.
    Shin HS; Snyderman R; Friedman E; Mellors A; Mayer MM
    Science; 1968 Oct; 162(3851):361-3. PubMed ID: 4175690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes.
    Kay AB
    Clin Exp Immunol; 1970 Nov; 7(5):723-37. PubMed ID: 4992784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-derived leukotactic factors in inflammatory synovial fluids of humans.
    Ward PA; Zvaifler NJ
    J Clin Invest; 1971 Mar; 50(3):606-16. PubMed ID: 5545123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement.
    Orr W; Varani J; Ward PA
    Am J Pathol; 1978 Nov; 93(2):405-22. PubMed ID: 568888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotactic factor inactivator in normal human serum.
    Berenberg JL; Ward PA
    J Clin Invest; 1973 May; 52(5):1200-6. PubMed ID: 4121701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.
    da Silva WD; Eisele JW; Lepow IH
    J Exp Med; 1967 Dec; 126(6):1027-48. PubMed ID: 6069927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.
    Bokisch VA; Müller-Eberhard HJ; Cochrane CG
    J Exp Med; 1969 May; 129(5):1109-30. PubMed ID: 5778786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.